2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast CancerAdvanced HR+/HER2- Breast CancerRecruitingPhase 12026-10-09NCT07604571
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of OfatumumabRelapsing Multiple Sclerosis (RMS)Active, not recruitingPhase 32026-08-10NCT06869785